| Stress and reproduction: controversies and challenges D Chand, DA Lovejoy General and comparative endocrinology 171 (3), 253-257, 2011 | 106 | 2011 |
| Selective FcγR co-engagement on APCs modulates the activity of therapeutic antibodies targeting T cell antigens JD Waight, D Chand, S Dietrich, R Gombos, T Horn, AM Gonzalez, ... Cancer Cell 33 (6), 1033-1047. e5, 2018 | 81 | 2018 |
| Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment VA Arrieta, C Dmello, DJ McGrail, DJ Brat, C Lee-Chang, AB Heimberger, ... The Journal of Clinical Investigation 133 (2), 2023 | 48 | 2023 |
| C-terminal processing of the teneurin proteins: independent actions of a teneurin C-terminal associated peptide in hippocampal cells D Chand, CA Casatti, L de Lannoy, L Song, A Kollara, D Barsyte-Lovejoy, ... Molecular and Cellular Neuroscience 52, 38-50, 2013 | 46 | 2013 |
| C-Terminal region of teneurin-1 co-localizes with dystroglycan and modulates cytoskeletal organization through an extracellular signal-regulated kinase-dependent stathmin-and … D Chand, L Song, L Delannoy, D Barsyte-Lovejoy, S Ackloo, PC Boutros, ... Neuroscience 219, 255-270, 2012 | 46 | 2012 |
| Identification of members of the gonadotropin-releasing hormone (GnRH), corticotropin-releasing factor (CRF) families in the genome of the holocephalan, Callorhinchus milii … TG Nock, D Chand, DA Lovejoy General and Comparative Endocrinology 171 (2), 237-244, 2011 | 36 | 2011 |
| Origin of chordate peptides by horizontal protozoan gene transfer in early metazoans and protists: evolution of the teneurin C-terminal associated peptides (TCAP) D Chand, L de Lannoy, R Tucker, DA Lovejoy General and comparative endocrinology 188, 144-150, 2013 | 29 | 2013 |
| Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody RB Gombos, A Gonzalez, M Manrique, D Chand, D Savitsky, B Morin, ... PLoS One 13 (4), e0191926, 2018 | 21 | 2018 |
| Modulation of neuroplastic changes and corticotropin-releasing factor-associated behavior by a phylogenetically ancient and conserved peptide family LA Tan, D Chand, R De Almeida, M Xu, L De Lannoy, DA Lovejoy General and Comparative Endocrinology 176 (3), 309-313, 2012 | 19 | 2012 |
| C-terminal region of teneurin-1 co-localizes with the dystroglycan complex in adult mouse testes and regulates testicular size and testosterone production D Chand, M Colacci, K Dixon, A Kollara, TJ Brown, DA Lovejoy Histochemistry and cell biology 141, 191-211, 2014 | 18 | 2014 |
| Identification of a novel brain derived neurotrophic factor (BDNF)-inhibitory factor: regulation of BDNF by teneurin C-terminal associated peptide (TCAP)-1 in immortalized … T Ng, D Chand, L Song, A Al Chawaf, JD Watson, PC Boutros, ... Regulatory Peptides 174 (1-3), 79-89, 2012 | 18 | 2012 |
| Characterization of the teneurin C-terminal associated peptide (TCAP) in the vase tunicate, Ciona intestinalis: a novel peptide system associated with energy metabolism and … M Colacci, R De Almeida, D Chand, SR Lovejoy, D Sephton, ... General and comparative endocrinology 216, 161-170, 2015 | 15 | 2015 |
| deLannoy L., Barsyte-Lovejoy D., Ackloo S., Boutros PC, et al..(2012) D Chand, L Song C-Terminal region of teneurin-1 co-localizes with dystroglycan and modulates …, 0 | 6 | |
| Anti-CD137 antibodies and methods of use thereof Y Xiao, NS Wilson, BM Morin, MA Findeis, CA Mundt, M Van Dijk, ... US Patent 11,242,385, 2022 | 5 | 2022 |
| 778 Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in “cold” and IO refractory metastatic solid tumors B Wilky, K Margolin, RE Sanborn, S O'Day | 5 | 2022 |
| Anti-TIGIT antibodies and methods of use thereof DS Chand, NS Wilson, DJ Underwood, BM Morin US Patent 11,021,537, 2021 | 5 | 2021 |
| 377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects C Galand, V Venkatraman, M Marques, J Strauss, R Carvajal, M Lim, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | 5 | 2020 |
| FcgR co-engagement by anti-TIGIT monoclonal antibodies enhances T cell functionality and antitumor immune responses D Chand, JD Waight, E Paltrinieri, S Dietrich, M Bushell, M Costa, ... Cancer Research 79 (13_Supplement), 2390-2390, 2019 | 5 | 2019 |
| AGEN1181, a clinical stage Fc-engineered anti-CTLA-4 antibody with improved therapeutic potential for the treatment of patients with advanced malignancies S O’Day, C Ramamurthy, AJ Bullock, AB El-Khoueiry, L Ohanjanian, ... J. Clin. Oncol 38, 2020 | 3 | 2020 |
| AGEN2034, a novel anti-PD-1 antibody that combines effectively with CTLA-4 pathway blockade to enhance T cell activity D Chand, D Savitsky, A Gonzalez, M Manrique, C Clarke, A Schuster, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017 | 3 | 2017 |
David A LovejoyEmeritus Professor of Neuroendocrinology, University of Toronto; Toronto, Canada.Verified email at utoronto.ca
